MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with I

Ibandronic acid

Ibandronic acid 50mg tablets

Incompatible

Stability notes for Ibandronic acid 50mg tablets

Protect from moisture. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bondronat 50mg tablets (Atnahs Pharma UK Ltd).

Suppliers (9) of Ibandronic acid 50mg tablets
Bondronat 50mg tablets (Atnahs Pharma UK Ltd)
Ibandronic acid 50mg tablets (A A H Pharmaceuticals Ltd)
Ibandronic acid 50mg tablets (Accord-UK Ltd)
Ibandronic acid 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Ibandronic acid 50mg tablets (Aspire Pharma Ltd)
Ibandronic acid 50mg tablets (Consilient Health Ltd)
Ibandronic acid 50mg tablets (Medihealth (Northern) Ltd)
Ibandronic acid 50mg tablets (Phoenix Healthcare Distribution Ltd)
Ibandronic acid 50mg tablets (Sigma Pharmaceuticals Plc)

Ibandronic acid 150mg tablets

Incompatible

Stability notes for Ibandronic acid 150mg tablets

No special precautions for storage. Monthly preparation. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bonviva 150mg tablets (Atnahs Pharma UK Ltd).

Suppliers (14) of Ibandronic acid 150mg tablets
Bonviva 150mg tablets (Atnahs Pharma UK Ltd)
Bonviva 150mg tablets (CST Pharma Ltd)
Bonviva 150mg tablets (Sigma Pharmaceuticals Plc)
Ibandronic acid 150mg tablets (A A H Pharmaceuticals Ltd)
Ibandronic acid 150mg tablets (Accord-UK Ltd)
Ibandronic acid 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Ibandronic acid 150mg tablets (Aspire Pharma Ltd)
Ibandronic acid 150mg tablets (Consilient Health Ltd)
Ibandronic acid 150mg tablets (Crescent Pharma Ltd)
Ibandronic acid 150mg tablets (Medihealth (Northern) Ltd)
Ibandronic acid 150mg tablets (Phoenix Healthcare Distribution Ltd)
Ibandronic acid 150mg tablets (Sandoz Ltd)
Ibandronic acid 150mg tablets (Sigma Pharmaceuticals Plc)
Ibandronic acid 150mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.